These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17489723)

  • 21. A case of ziprasidone associated with acutely worsened diabetes mellitus.
    Honigberg MC; Bui MP; Coconcea C
    Psychosomatics; 2013; 54(3):304-5. PubMed ID: 23680062
    [No Abstract]   [Full Text] [Related]  

  • 22. Galactorrhea and hyperprolactinemia in schizophrenic patients on neuroleptics: frequency and etiology.
    Windgassen K; Wesselmann U; Schulze Mönking H
    Neuropsychobiology; 1996; 33(3):142-6. PubMed ID: 8776743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin syndrome caused by ziprasidone alone.
    Lin PY; Hong CJ; Tsai SJ
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):338-9. PubMed ID: 20602736
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Montejo AL; Rico-Villademoros F;
    J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
    [No Abstract]   [Full Text] [Related]  

  • 25. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases.
    Eker SS; Sarandol A; Akkaya C; Sivrioglu EY; Kirli S
    J Psychopharmacol; 2009 Nov; 23(8):993-6. PubMed ID: 18635710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ziprasidone induced symptomatic bradycardia: a case report.
    Menon V; Kattimani S; Ayyanar S
    Aust N Z J Psychiatry; 2011 Sep; 45(9):789. PubMed ID: 21668298
    [No Abstract]   [Full Text] [Related]  

  • 28. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
    Chen HK; Chen CK; Tzeng NS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
    [No Abstract]   [Full Text] [Related]  

  • 29. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ziprasidone-induced hypersensitivity syndrome in an aged schizophrenia patient.
    Tsai CF; Tsai SJ; Hwang JP
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):797-9. PubMed ID: 16035110
    [No Abstract]   [Full Text] [Related]  

  • 31. The highest intentional ziprasidone overdose was not fatal.
    Prieto T; Benabarre A; Bernardo M
    Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953
    [No Abstract]   [Full Text] [Related]  

  • 32. Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
    Kim MS; Kim SW; Han TY; Son SJ; Lee JH; Kim EJ
    Int J Dermatol; 2014 Apr; 53(4):e267-8. PubMed ID: 24117439
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-Induced Systemic Hypersensitivity Reaction Associated With Ziprasidone: An Atypical Occurrence.
    Lister JF; Voinov B; Thimothy L; Bean JR
    J Clin Psychopharmacol; 2015 Aug; 35(4):478-80. PubMed ID: 26120944
    [No Abstract]   [Full Text] [Related]  

  • 34. Transient, asymptomatic, fluctuating bradycardia with oral ziprasidone in an older woman.
    Menon V; Ramamourthy P; Ayyanar S
    Aust N Z J Psychiatry; 2014 Feb; 48(2):201-2. PubMed ID: 23934959
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term safety of ziprasidone in schizophrenic patients: an open trial.
    Sciarretta A; Piazzi G
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2113-9. PubMed ID: 23280028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ziprasidone and the relative risk of diabetes.
    Vanderburg D; Keohane D; Karayal ON; Pappadopulos E
    Br J Psychiatry; 2011 Feb; 198(2):157-8; author reply 158. PubMed ID: 21282789
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperosmolar hyperglycemic state associated with ziprasidone treatment: a case report.
    Létourneau G; Abdel-Baki A; Dubreucq S; Mahone M; Granger B
    J Clin Psychopharmacol; 2011 Oct; 31(5):671-3. PubMed ID: 21881458
    [No Abstract]   [Full Text] [Related]  

  • 38. High-dose ziprasidone-induced acute dystonia.
    Rosenfield PJ; Girgis RR; Gil R
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):546-7. PubMed ID: 17123682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.
    Rocha FL; Hara C; Ramos MG; Kascher GG; Santos MA; de Oliveira Lança G; Magalhães Scoralick F
    Dement Geriatr Cogn Disord; 2006; 22(5-6):445-8. PubMed ID: 16983187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tardive dyskinesia and ziprasidone.
    Rosenquist KJ; Walker SS; Ghaemi SN
    Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.